It seems like Boston Scientific really wants this deal and will pull out all the stops to get it. It's a very rare asset. Cardiac rhythm management has $10 billion and only three companies.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Got It!," you consent to our use of cookies.